Efficacy and Safety of Dapagliflozin in Patients Over 75 Years Old With Heart Failure With Preserved Ejection Fraction: A Retrospective Study
Dapagliflozin administration in HFpEF patients over 75 years significantly enhances cardiac function and exercise capacity, as well as improves quality of life markers, without notable safety concerns.
Authors
- Zhanliang Li
- Juan Wang
- Guiyue Zhu
Institutions
- Fourth People’s Hospital of Jinan (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- British Journal of Hospital Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.31083/bjhm50721
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00